Rummelt Andreas
Director at ALEXION PHARMACEUTICALS INC
- Sold, on record
- $4M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Aug 25, 2014
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ALEXION PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedOct 24, 2011 2011
Sold 9,015 shares at $69.01 ($622k)
Rummelt Andreas, Director
Sold 24.9% of holdings ($2.5M position)27,200 shares leftFirst sale on recordFiling
- 2 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedFeb 23, 2012 +122 days
Sold 6,443 shares at $83.36 ($537k)
Rummelt Andreas, Director
Sold 17.5% of holdings ($3.1M position)30,315 shares leftFiling
- 3 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualJun 7, 2012 +105 days
Sold 10,000 shares at $91.29 ($913k)
Rummelt Andreas, Director
Sold 33% of holdings ($2.8M position)20,315 shares leftFiling
- 4 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualJul 27, 2012 +50 days
Sold 10,000 shares at $107.00 ($1.1M)
Rummelt Andreas, Director
Sold 49.2% of holdings ($2.2M position)10,315 shares left1.1x usual sizeFiling
- 5 Form 4 sale ALEXION PHARMACEUTICALS INCUnusualAug 25, 2014 +759 days
Sold 5,052 shares at $170.53 ($862k)
Rummelt Andreas, Director
Sold 28.3% of holdings ($3M position)12,786 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2014 | Aug 27, 2014 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 5,052 | $862k | 28.3% | Unusual | SEC |
| Jul 27, 2012 | Jul 31, 2012 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 10,000 | $1.1M | 49.2% | Unusual | SEC |
| Jun 7, 2012 | Jun 8, 2012 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 10,000 | $913k | 33.0% | Unusual | SEC |
| Feb 23, 2012 | Feb 23, 2012 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 6,443 | $537k | 17.5% | Plan not stated | SEC |
| Oct 24, 2011 | Oct 25, 2011 | ALEXION PHARMACEUTICALS INC | Director | Form 4 sale | 9,015 | $622k | 24.9% | Plan not stated | SEC |